Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220687401> ?p ?o ?g. }
- W4220687401 endingPage "513" @default.
- W4220687401 startingPage "513" @default.
- W4220687401 abstract "The worldwide pandemic of coronavirus disease 2019 (COVID-19) has imposed a challenge on human health worldwide, and vaccination represents a vital strategy to control the pandemic. To date, multiple COVID-19 vaccines have been granted emergency use authorization, including inactivated vaccines, adenovirus-vectored vaccines, and nucleic acid vaccines. These vaccines have different technical principles, which will necessarily lead to differences in safety and efficacy. Therefore, we aim to implement a systematic review by synthesizing clinical experimental data combined with mass vaccination data and conducting a synthesis to evaluate the safety and efficacy of COVID-19 vaccines. Compared with other vaccines, adverse reactions after vaccination with inactivated vaccines are relatively low. The efficacy of inactivated vaccines is approximately 60%, adenovirus-vectored vaccines are 65%, and mRNA vaccines are 90%, which are always efficient against asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, symptomatic COVID-19, COVID-19 hospitalization, severe or critical hospitalization, and death. RNA-based vaccines have a number of advantages and are one of the most promising vaccines identified to date and are particularly important during a pandemic. However, further improvements are required. In time, all the antibody levels weaken gradually, so a booster dose is needed to maintain immunity. Compared with homologous prime-boost immunization, heterologous prime-boost immunization prompts more robust humoral and cellular immune responses." @default.
- W4220687401 created "2022-04-03" @default.
- W4220687401 creator A5018999020 @default.
- W4220687401 creator A5060002817 @default.
- W4220687401 date "2022-03-25" @default.
- W4220687401 modified "2023-10-02" @default.
- W4220687401 title "Safety and Efficacy of the Common Vaccines against COVID-19" @default.
- W4220687401 cites W1999546368 @default.
- W4220687401 cites W2004583429 @default.
- W4220687401 cites W2074311607 @default.
- W4220687401 cites W2084534408 @default.
- W4220687401 cites W2084667813 @default.
- W4220687401 cites W2117549098 @default.
- W4220687401 cites W2142239745 @default.
- W4220687401 cites W2153670011 @default.
- W4220687401 cites W2157793875 @default.
- W4220687401 cites W2165039106 @default.
- W4220687401 cites W2177916781 @default.
- W4220687401 cites W2752960590 @default.
- W4220687401 cites W2970922758 @default.
- W4220687401 cites W3001897055 @default.
- W4220687401 cites W3004539389 @default.
- W4220687401 cites W3007643904 @default.
- W4220687401 cites W3018517500 @default.
- W4220687401 cites W3022917947 @default.
- W4220687401 cites W3024818377 @default.
- W4220687401 cites W3025521550 @default.
- W4220687401 cites W3027138240 @default.
- W4220687401 cites W3033731962 @default.
- W4220687401 cites W3034928620 @default.
- W4220687401 cites W3042383115 @default.
- W4220687401 cites W3049348882 @default.
- W4220687401 cites W3053491827 @default.
- W4220687401 cites W3087239253 @default.
- W4220687401 cites W3093367571 @default.
- W4220687401 cites W3094292484 @default.
- W4220687401 cites W3097745040 @default.
- W4220687401 cites W3101925386 @default.
- W4220687401 cites W3102328262 @default.
- W4220687401 cites W3108610942 @default.
- W4220687401 cites W3111255098 @default.
- W4220687401 cites W3117730334 @default.
- W4220687401 cites W3122700430 @default.
- W4220687401 cites W3125405808 @default.
- W4220687401 cites W3128702325 @default.
- W4220687401 cites W3131348899 @default.
- W4220687401 cites W3134831990 @default.
- W4220687401 cites W3140226555 @default.
- W4220687401 cites W3153482671 @default.
- W4220687401 cites W3154965281 @default.
- W4220687401 cites W3158276912 @default.
- W4220687401 cites W3158811938 @default.
- W4220687401 cites W3163739433 @default.
- W4220687401 cites W3164788651 @default.
- W4220687401 cites W3172271359 @default.
- W4220687401 cites W3173690790 @default.
- W4220687401 cites W3174711906 @default.
- W4220687401 cites W3176051599 @default.
- W4220687401 cites W3178010802 @default.
- W4220687401 cites W3179399516 @default.
- W4220687401 cites W3183750507 @default.
- W4220687401 cites W3184287782 @default.
- W4220687401 cites W3185367618 @default.
- W4220687401 cites W3201089993 @default.
- W4220687401 cites W3202094457 @default.
- W4220687401 cites W3206895259 @default.
- W4220687401 cites W3207690539 @default.
- W4220687401 cites W4200135346 @default.
- W4220687401 cites W4210301583 @default.
- W4220687401 cites W4210603043 @default.
- W4220687401 cites W4212940536 @default.
- W4220687401 cites W4220701094 @default.
- W4220687401 cites W4226229183 @default.
- W4220687401 cites W4226246286 @default.
- W4220687401 cites W4226299805 @default.
- W4220687401 doi "https://doi.org/10.3390/vaccines10040513" @default.
- W4220687401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35455262" @default.
- W4220687401 hasPublicationYear "2022" @default.
- W4220687401 type Work @default.
- W4220687401 citedByCount "24" @default.
- W4220687401 countsByYear W42206874012022 @default.
- W4220687401 countsByYear W42206874012023 @default.
- W4220687401 crossrefType "journal-article" @default.
- W4220687401 hasAuthorship W4220687401A5018999020 @default.
- W4220687401 hasAuthorship W4220687401A5060002817 @default.
- W4220687401 hasBestOaLocation W42206874011 @default.
- W4220687401 hasConcept C142724271 @default.
- W4220687401 hasConcept C159047783 @default.
- W4220687401 hasConcept C167508917 @default.
- W4220687401 hasConcept C203014093 @default.
- W4220687401 hasConcept C22070199 @default.
- W4220687401 hasConcept C2779134260 @default.
- W4220687401 hasConcept C2779341262 @default.
- W4220687401 hasConcept C2780441014 @default.
- W4220687401 hasConcept C2780801004 @default.
- W4220687401 hasConcept C3008058167 @default.
- W4220687401 hasConcept C524204448 @default.
- W4220687401 hasConcept C71924100 @default.